Evidence map›Paper›PMID 34076405›Full record

ArticleACS infectious diseases2021

Group B

Kristen Noble, Jacky Lu, Miriam A Guevara, Ryan S Doster, Schuyler A Chambers, Lisa M Rogers, Rebecca E Moore, Sabrina K Spicer, Alison J Eastman, Jamisha D Francis and 5 more

Open access · greenAbstract read
In one paragraph

Article in ACS infectious diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
6.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 49 citations in OpenAlex.

  1. Microbiology (Reading, England) · 2026
    Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Matrine AttenuatesMicroorganisms · 2025
    Article
  9. Identification of glyoxalase A in group BInfection and immunity · 2025
    Article
  10. A CRISPRi library screen in group BInfection and immunity · 2025
    Article
  11. Article
  12. Identification of Glyoxalase A in Group BbioRxiv : the preprint server for biology · 2024
    Article
  13. A CRISPRi Library Screen in Group BbioRxiv : the preprint server for biology · 2024
    Article
  14. Re-framing the importance of Group BInfection and immunity · 2024
    Review
  15. Article
  16. Capsule production promotes Group BMicrobiology spectrum · 2023
    Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 1 country.

Kristen NobleDepartment of Pediatrics, Vanderbilt University School of Medicine, Nashville, Tennessee 37212, United States.
Jacky LuDepartment of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee 37212, United States.
Miriam A GuevaraDepartment of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee 37212, United States.
Ryan S DosterDepartment of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee 37212, United States.
Schuyler A ChambersDepartment of Chemistry, Vanderbilt University, Nashville, Tennessee 37235, United States.ORCID 0000-0002-3557-830X
Lisa M RogersDepartment of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee 37212, United States.
Rebecca E MooreDepartment of Chemistry, Vanderbilt University, Nashville, Tennessee 37235, United States.
Sabrina K SpicerDepartment of Chemistry, Vanderbilt University, Nashville, Tennessee 37235, United States.
Alison J EastmanDepartment of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee 37212, United States.
Jamisha D FrancisDepartment of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee 37212, United States.
Shannon D ManningDepartment of Microbiology and Molecular Genetics, Michigan State University, East Lansing, Michigan 48823, United States.
Lakshmi RajagopalDepartment of Pediatrics, University of Washington, Seattle, Washington 98109, United States.
David M AronoffDepartment of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee 37212, United States.
Steven D TownsendDepartment of Chemistry, Vanderbilt University, Nashville, Tennessee 37235, United States.ORCID 0000-0001-5362-7235
Jennifer A GaddyDepartment of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee 37212, United States.ORCID 0000-0002-2192-4224
Vanderbilt University · USVanderbilt University Medical Center · USMichigan State University · USUniversity of Washington · US

Funding

Tumor Immunology and Microenvironment Research ProgramP30CA068485 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI STACIE B DUSETZINA · 1995 to 2026
$172.8M
VANDERBILT UNIVERSITY CTSA FOR PEDIATRIC RESEARCHUL1RR024975 · NCRR · VANDERBILT UNIVERSITY · PI BERNARD, GORDON RAPHAEL · 2007 to 2011
$45.7M
Pediatric Scientist Development Program (PSDP) [K12]K12HD000850 · NICHD · YALE UNIVERSITY · PI Sallie R. Permar · 1987 to 2026
$44.1M
The Vanderbilt Institute for Clinical and Translational Research (VICTR)UL1TR000445 · NCATS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BERNARD, GORDON RAPHAEL · 2012 to 2016
$41.4M
Translational Analysis CoreP30DK058404 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI RICHARD M. PEEK · 2002 to 2026
$29.9M
Vanderbilt Diabetes Research CenterP30DK020593 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI ALVIN C POWERS · 2012 to 2026
$29.3M
Shop Module CoreP30EY008126 · NEI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI David J. Calkins · 1989 to 2026
$19.6M
Vanderbilt Mouse Metabolic Physiology CenterU24DK059637 · NIDDK · VANDERBILT UNIVERSITY · PI WASSERMAN, DAVID H · 2001 to 2015
$14.9M
Training In Cardiovascular ResearchT32HL007411 · NHLBI · VANDERBILT UNIVERSITY · PI BECKMAN, JOSHUA A · 1985 to 2020
$7.2M
Chemical Biology of Infectious Diseases (CBID) Training ProgramT32AI112541 · NIAID · VANDERBILT UNIVERSITY · PI Eric P Skaar · 2015 to 2026
$4.0M
Repurposing misoprostol to prevent recurrence of Clostridium difficile infectionU01TR002398 · NCATS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI DOSTER, RYAN S, DUBBERKE, ERIK R · 2018 to 2019
$3.1M
Bioorganic Approaches Toward Novel Antimicrobial Agents and ChemotherapeuticsR35GM133602 · NIGMS · VANDERBILT UNIVERSITY · PI Steven D. Townsend · 2019 to 2026
$3.0M
BLRD VA I01 BX005352NCATS NIH HHS U01 TR002398NCATS NIH HHS UL1 TR000445NCI NIH HHS P30 CA068485NCRR NIH HHS S10 RR026373NCRR NIH HHS S10 RR027396NCRR NIH HHS UL1 RR024975NEI NIH HHS P30 EY008126NHLBI NIH HHS T32 HL007411NIAID NIH HHS K08 AI151100NIAID NIH HHS R01 AI134036NIAID NIH HHS T32 AI112541NICHD NIH HHS F32 HD100087NICHD NIH HHS K12 HD000850NICHD NIH HHS R01 HD090061NIDDK NIH HHS P30 DK020593NIDDK NIH HHS P30 DK058404NIDDK NIH HHS U24 DK059637NIGMS NIH HHS R35 GM133602
6 · The paper itself

Abstract

Group B

Indexed as

Bacterial CapsulesPlacentaAnimalsBiofilmsFemaleMicePregnancySerogroupStreptococcus agalactiaecapsulecarbohydrateinnate immunitypathogenesisStreptococcus

Identifiers

PMID34076405
PMCPMC8588567
OpenAlexW3164008017

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.